Close Menu

NEW YORK – The European Society for Medical Oncology on Tuesday published a set of guidelines detailing how next-generation sequencing should be used as part of routine clinical practice.

In addition to discussing the use of NGS across various cancer types, the guidelines address whether broad-based NGS should replace small panels designed to test a single gene or a handful of genes.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.